Erytropoietin is a glycoprotein cytokine secreted by the kidney in response to cellular hypoxia. It is also called as hematopoeitin or hemopoeitin. These drugs are given by injection and they stimulate red blood cells production in the bone marrow.
The global Erytropoietin drugs market is thus driven by increasing number of patients suffering from anemic condition induced due to cancer, HIV and ESRD treatment, favorable reimbursements and increasing commercialization of Erytropoietin biosimilars. There are distinctive kinds of erythropoietin drugs accessible in market, for example, Procrit, Epogen and Aranesp. Epogen is the principal blockbuster biologic for paleness by Amegen endorsed by the FDA and is generally utilized.
Erytropoeitin Drugs Market Forecast Report (2018-2023)
Erytropoeitin Drugs Market is worth USD 9.94 billion in 2018 and estimated to grow at a CAGR of 9.7%, to reach USD 15.79 billion by 2023.
Browse Report Brief and TOC @ https://www.marketdataforecast.com/market-reports/erythropoietin-drugs-market-6767/
Erytropoeitin Drugs Market Segmentation
The Global market for Erytropoeitin Drugs is segmented on the basis of product, application and drug class. On the basis of product, the market is segmented into Epoetin-alpha, epoetin-beta, darbepoetin-alfa and others. Epoietin-alfa holds the largest market share. By application the market is classified into cancer, haematology, renal diseases and neurology. By drug class the market is segmented into biologics and biosimilar.
Geographically, the Erytropoeitin Drugs market is fragmented into Asia-Pacific, North America, Europe, Latin America and Middle East Asia. Europe is estimated to constitute the largest share in this market, followed by North America. Asia Pacific is expected to witness the high CGAR.
The major companies dominating this market for its products and services are
- Intas Pharmaceuticals Ltd.
- Biocon Ltd.
- LG Life Sciences Ltd.
- Hoffmann-La Roche Inc.
- Amgen Dr. Reddy’s Laboratories Ltd.
- Sun Pharmaceutical Industries Ltd.
- Johnson & Johnson
- Celltrion, Inc
- Teva Pharmaceutical Industries
Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients.
Company Name: Market Data Forecast
Contact Person: Abhishek Shukla
Email: Send Email
Address:2nd Floor, Lakeview Plaza, Kavuri Hills, flimnagar